Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3860
-0.0009 (-0.23%)
At close: Mar 13, 2026, 4:00 PM EDT
0.3890
+0.0030 (0.78%)
After-hours: Mar 13, 2026, 7:49 PM EDT

Mereo BioPharma Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
--10-49.3-
Cost of Revenue
--2.57-1.1324.21-
Gross Profit
--7.431.1325.09-
Selling, General & Admin
25.2726.4318.4223.6421.5429.01
Research & Development
22.3920.9317.4230.231.8522.35
Other Operating Expenses
0.3-----
Total Operating Expenses
47.9647.3635.8453.8453.3951.36
Operating Income
-46.99-47.36-28.42-52.71-28.31-51.36
Interest Income
2.633.042.130.8400.06
Interest Expense
-0.61-1.37-2.88-3.52-5.44-8.73
Other Non-Operating Income (Expense)
3.392.44-0.8312.8853-167.54
Total Non-Operating Income (Expense)
5.424.11-1.5810.247.56-176.21
Pretax Income
-41.57-43.25-30-42.5119.25-227.57
Provision for Income Taxes
---0.53-2.292.05-3.86
Net Income
-41.57-43.25-29.47-40.2117.2-223.71
Net Income to Common
-41.57-43.25-29.47-40.2117.2-223.71
Shares Outstanding (Basic)
47514813212110668
Shares Outstanding (Diluted)
47514813212111168
Shares Change (YoY)
-9.07%12.16%9.33%8.63%63.82%279.04%
EPS (Basic)
-0.25-0.30-0.20-0.330.14-3.28
EPS (Diluted)
-0.25-0.30-0.20-0.33-0.34-3.28
Free Cash Flow
-32.74-32.83-21.13-46.98-7.81-38.77
Free Cash Flow Per Share
-0.07-0.22-0.16-0.39-0.07-0.57
Gross Margin
--74.26%-50.89%-
Operating Margin
---284.16%--57.42%-
Profit Margin
---294.66%-34.90%-
FCF Margin
---211.32%--15.83%-
EBITDA
-46.16-46.28-27.36-51.83-27.44-49.18
EBITDA Margin
---273.55%--55.65%-
EBIT
-46.99-47.36-28.42-52.71-28.31-51.36
EBIT Margin
---284.16%--57.42%-
Effective Tax Rate
-0.00%1.77%5.40%10.65%1.70%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q